The results showed that the cytotoxicity of T lymphocytes against CCA cells was significantly enhanced, especially after gemcitabine treatment, and the cytotoxicity was positively correlated with the level of PD-L1 expression. The gene discussed is CD274; the disease is cholangiocarcinoma.